Risk factors for disease progression in fibrotic hypersensitivity pneumonitis

Eur Respir J. 2023 Jan 27;61(1):2201706. doi: 10.1183/13993003.01706-2022. Print 2023 Jan.

Authors

Hajime Fujimoto¹, Taro Yasuma², Corina N D'Alessandro-Gabazza², Esteban C Gabazza³, Osamu Hataji⁴, Tetsu Kobayashi¹

Affiliations

¹ Department of Pulmonary and Critical Care Medicine, Mie University Faculty and Graduate School of Medicine, Tsu, Japan.
² Department of Immunology, Mie University Faculty and Graduate School of Medicine, Tsu, Japan.
³ Department of Immunology, Mie University Faculty and Graduate School of Medicine, Tsu, Japan gabazza@doc.medic.mie-u.ac.jp.
⁴ Respiratory Center, Matsusaka Municipal Hospital, Matsusaka, Japan.

PMID: 36549705
DOI: 10.1183/13993003.01706-2022

No abstract available

Publication types

Letter
Comment

MeSH terms

Alveolitis, Extrinsic Allergic*
Disease Progression
Humans
Lung Diseases, Interstitial*
Prevalence
Risk Factors